A industry-backed study estimates potential losses for the Swiss pharma industry from US policies could be in the billions.

Boss of Swiss pharma research association bemoans political pressure of drug prices.

A industry-backed study estimates potential losses for the Swiss pharma industry from US policies could be in the billions.